__timestamp | Alnylam Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
---|---|---|
Wednesday, January 1, 2014 | 50561000 | 20272000000 |
Thursday, January 1, 2015 | 41097000 | 19652000000 |
Friday, January 1, 2016 | 47159000 | 21903000000 |
Sunday, January 1, 2017 | 89912000 | 22385000000 |
Monday, January 1, 2018 | 74908000 | 18854000000 |
Tuesday, January 1, 2019 | 219750000 | 16887000000 |
Wednesday, January 1, 2020 | 492853000 | 16658000000 |
Friday, January 1, 2021 | 844287000 | 15878000000 |
Saturday, January 1, 2022 | 1037418000 | 14925000000 |
Sunday, January 1, 2023 | 1828292000 | 15846000000 |
Monday, January 1, 2024 | 2248243000 | 16544000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, revenue performance is a key indicator of a company's market position and growth potential. Alnylam Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited, two prominent players, have shown contrasting revenue trajectories from 2014 to 2023. Alnylam, a leader in RNA interference therapeutics, has seen its revenue skyrocket by over 3,500% during this period, reflecting its innovative breakthroughs and expanding market reach. In contrast, Teva, a global leader in generic drugs, experienced a 22% decline in revenue, highlighting challenges in the generic drug market and increased competition. This comparison underscores the dynamic nature of the pharmaceutical sector, where innovation and adaptability are crucial for sustained growth. As we look to the future, the strategic decisions made by these companies will be pivotal in shaping their financial landscapes.
Comparing Revenue Performance: Zoetis Inc. or Teva Pharmaceutical Industries Limited?
Who Generates More Revenue? GSK plc or Teva Pharmaceutical Industries Limited
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Revenue Showdown: Alnylam Pharmaceuticals, Inc. vs Perrigo Company plc
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Revenue Insights: Alnylam Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or MiMedx Group, Inc.?
Teva Pharmaceutical Industries Limited or Jazz Pharmaceuticals plc: Who Leads in Yearly Revenue?
Teva Pharmaceutical Industries Limited vs MiMedx Group, Inc.: Examining Key Revenue Metrics